# Effect of Vitamin D on Drug Resistant Helicobacter Pylori (HP) Eradication Study

> **NCT03142620** · PHASE3 · UNKNOWN · sponsor: **Chinese University of Hong Kong** · enrollment: 96 (estimated)

## Conditions studied

- H. Pylori Infection

## Interventions

- **DRUG:** Esomeprazole
- **DRUG:** Amoxicillin-Potassium Clavulanate Combination
- **DRUG:** Clarithromycin
- **DRUG:** Vitamin D3

## Key facts

- **NCT ID:** NCT03142620
- **Lead sponsor:** Chinese University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-03
- **Primary completion:** 2017-12
- **Final completion:** 2017-12
- **Target enrollment:** 96 (ESTIMATED)
- **Last updated:** 2017-05-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03142620

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03142620, "Effect of Vitamin D on Drug Resistant Helicobacter Pylori (HP) Eradication Study". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03142620. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*